[HTML][HTML] Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by …
XQ Tian, YJ Yang, Q Li, J Xu, PS Huang… - American Journal of …, 2019 - ncbi.nlm.nih.gov
Abstract The SDF-1/CXCR4 signaling plays a critical role in the trafficking of mesenchymal
stem cells (MSCs) to the sites of tissue damage. Our recent study demonstrated that …
stem cells (MSCs) to the sites of tissue damage. Our recent study demonstrated that …
[PDF][PDF] Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by …
XQ Tian, YJ Yang, Q Li, J Xu, PS Huang, YY Xiong… - Am J Transl Res, 2019 - e-century.us
The SDF-1/CXCR4 signaling plays a critical role in the trafficking of mesenchymal stem cells
(MSCs) to the sites of tissue damage. Our recent study demonstrated that atorvastatin (ATV) …
(MSCs) to the sites of tissue damage. Our recent study demonstrated that atorvastatin (ATV) …
[PDF][PDF] Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by …
XQ Tian, YJ Yang, Q Li, J Xu, PS Huang… - Am J Transl …, 2019 - researchgate.net
The SDF-1/CXCR4 signaling plays a critical role in the trafficking of mesenchymal stem cells
(MSCs) to the sites of tissue damage. Our recent study demonstrated that atorvastatin (ATV) …
(MSCs) to the sites of tissue damage. Our recent study demonstrated that atorvastatin (ATV) …
Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating …
XQ Tian, YJ Yang, Q Li, J Xu, PS Huang… - American Journal of …, 2019 - europepmc.org
Abstract The SDF-1/CXCR4 signaling plays a critical role in the trafficking of mesenchymal
stem cells (MSCs) to the sites of tissue damage. Our recent study demonstrated that …
stem cells (MSCs) to the sites of tissue damage. Our recent study demonstrated that …
Combined therapy with atorvastatin and atorvastatin-pretreated mesenchymal stem cells enhances cardiac performance after acute myocardial infarction by activating …
XQ Tian, YJ Yang, Q Li, J Xu… - American journal …, 2019 - pubmed.ncbi.nlm.nih.gov
The SDF-1/CXCR4 signaling plays a critical role in the trafficking of mesenchymal stem cells
(MSCs) to the sites of tissue damage. Our recent study demonstrated that atorvastatin (ATV) …
(MSCs) to the sites of tissue damage. Our recent study demonstrated that atorvastatin (ATV) …